NOV Analyst Ratings
BenzingaApr 8 11:26 ET
Piper Sandler Adjusts NOV's Price Target to $22 From $25, Keeps Neutral Rating
MT NewswiresFeb 20 10:24 ET
NOV Analyst Ratings
BenzingaFeb 20 10:11 ET
Barclays Sticks to Its Sell Rating for NOV (NOV)
TipRanksFeb 7 20:25 ET
NOV Analyst Ratings
BenzingaFeb 6 10:57 ET
NOV (NOV) Gets a Hold From RBC Capital
TipRanksFeb 6 10:15 ET
NOV Analyst Ratings
BenzingaFeb 5 16:12 ET
NOV Analyst Ratings
BenzingaFeb 5 07:33 ET
NOV Analyst Ratings
BenzingaJan 16 15:06 ET
NOV Analyst Ratings
BenzingaDec 12, 2023 07:53 ET
NOV Upgraded at J.P. Morgan Even With Limited Upside for Oil Prices
Seeking AlphaDec 8, 2023 15:03 ET
NOV Analyst Ratings
BenzingaDec 8, 2023 06:39 ET
Goldman Sachs Raises Price Target on NOV to $19 From $18, Maintains Sell Rating
MT NewswiresNov 14, 2023 11:34 ET
RBC Capital Maintains Sector Perform on NOV, Raises Price Target to $24
BenzingaOct 30, 2023 14:29 ET
NOV Analyst Ratings
BenzingaOct 30, 2023 14:28 ET
RBC Lifts Price Target on NOV Inc. to $24 From $23, Keeps Sector Perform Rating
MT NewswiresOct 30, 2023 07:50 ET
NOV (NOV) Receives a Rating Update From a Top Analyst
TipRanksOct 30, 2023 06:29 ET
Nabors Upgraded, Patterson-UTI and ProFrac Downgraded at Morgan Stanley
Seeking AlphaOct 17, 2023 12:32 ET
Morgan Stanley Maintains Overweight on NOV, Raises Price Target to $25
BenzingaOct 17, 2023 10:29 ET
NOV Analyst Ratings
BenzingaOct 17, 2023 10:28 ET
No Data
No Data